Pubblicazioni

Approfondimenti generali
Caricnoma del rene, Linee Guida AIOM, 2019. [Apri]
Renal Cell Carcinoma: ESMO Clinical Practice Guidelines [Apri]
ClinicalTrial.gov. A service of the U.S. National Institutes of Health [Apri]
Referenze bibliografiche specifiche
Canino C, et al. Targeting angiogenesis in metastatic renal cell carcinoma. Expert Rev Anticancer Ther. 2019 Mar;19(3):245-257. [Apri]
Rini BI, et al. Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial. Lancet. 2019;393(10189):2404-2415 [Apri]
Rini BI, et al. Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma. N Engl J Med. 2019;380(12):1116-1127 [Apri]